An in vivo platform to select and evolve aggregation-resistant proteins
Protein aggregation remains a significant challenge for manufacturing of protein biopharmaceuticals. Here, the authors demonstrate the use of directed evolution and an assay for in vivo innate protein aggregation-propensity to generate aggregation-resistant scFv fragments.
Guardado en:
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7cd4d27ccee2435a841e247a296e334c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:7cd4d27ccee2435a841e247a296e334c |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:7cd4d27ccee2435a841e247a296e334c2021-12-02T14:40:38ZAn in vivo platform to select and evolve aggregation-resistant proteins10.1038/s41467-020-15667-12041-1723https://doaj.org/article/7cd4d27ccee2435a841e247a296e334c2020-04-01T00:00:00Zhttps://doi.org/10.1038/s41467-020-15667-1https://doaj.org/toc/2041-1723Protein aggregation remains a significant challenge for manufacturing of protein biopharmaceuticals. Here, the authors demonstrate the use of directed evolution and an assay for in vivo innate protein aggregation-propensity to generate aggregation-resistant scFv fragments.Jessica S. EboJanet C. SaundersPaul W. A. DevineAlice M. GordonAmy S. WarwickBob SchiffrinStacey E. ChinElizabeth EnglandJames D. ButtonChristopher LloydNicholas J. BondAlison E. AshcroftSheena E. RadfordDavid C. LoweDavid J. BrockwellNature PortfolioarticleScienceQENNature Communications, Vol 11, Iss 1, Pp 1-12 (2020) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q Jessica S. Ebo Janet C. Saunders Paul W. A. Devine Alice M. Gordon Amy S. Warwick Bob Schiffrin Stacey E. Chin Elizabeth England James D. Button Christopher Lloyd Nicholas J. Bond Alison E. Ashcroft Sheena E. Radford David C. Lowe David J. Brockwell An in vivo platform to select and evolve aggregation-resistant proteins |
description |
Protein aggregation remains a significant challenge for manufacturing of protein biopharmaceuticals. Here, the authors demonstrate the use of directed evolution and an assay for in vivo innate protein aggregation-propensity to generate aggregation-resistant scFv fragments. |
format |
article |
author |
Jessica S. Ebo Janet C. Saunders Paul W. A. Devine Alice M. Gordon Amy S. Warwick Bob Schiffrin Stacey E. Chin Elizabeth England James D. Button Christopher Lloyd Nicholas J. Bond Alison E. Ashcroft Sheena E. Radford David C. Lowe David J. Brockwell |
author_facet |
Jessica S. Ebo Janet C. Saunders Paul W. A. Devine Alice M. Gordon Amy S. Warwick Bob Schiffrin Stacey E. Chin Elizabeth England James D. Button Christopher Lloyd Nicholas J. Bond Alison E. Ashcroft Sheena E. Radford David C. Lowe David J. Brockwell |
author_sort |
Jessica S. Ebo |
title |
An in vivo platform to select and evolve aggregation-resistant proteins |
title_short |
An in vivo platform to select and evolve aggregation-resistant proteins |
title_full |
An in vivo platform to select and evolve aggregation-resistant proteins |
title_fullStr |
An in vivo platform to select and evolve aggregation-resistant proteins |
title_full_unstemmed |
An in vivo platform to select and evolve aggregation-resistant proteins |
title_sort |
in vivo platform to select and evolve aggregation-resistant proteins |
publisher |
Nature Portfolio |
publishDate |
2020 |
url |
https://doaj.org/article/7cd4d27ccee2435a841e247a296e334c |
work_keys_str_mv |
AT jessicasebo aninvivoplatformtoselectandevolveaggregationresistantproteins AT janetcsaunders aninvivoplatformtoselectandevolveaggregationresistantproteins AT paulwadevine aninvivoplatformtoselectandevolveaggregationresistantproteins AT alicemgordon aninvivoplatformtoselectandevolveaggregationresistantproteins AT amyswarwick aninvivoplatformtoselectandevolveaggregationresistantproteins AT bobschiffrin aninvivoplatformtoselectandevolveaggregationresistantproteins AT staceyechin aninvivoplatformtoselectandevolveaggregationresistantproteins AT elizabethengland aninvivoplatformtoselectandevolveaggregationresistantproteins AT jamesdbutton aninvivoplatformtoselectandevolveaggregationresistantproteins AT christopherlloyd aninvivoplatformtoselectandevolveaggregationresistantproteins AT nicholasjbond aninvivoplatformtoselectandevolveaggregationresistantproteins AT alisoneashcroft aninvivoplatformtoselectandevolveaggregationresistantproteins AT sheenaeradford aninvivoplatformtoselectandevolveaggregationresistantproteins AT davidclowe aninvivoplatformtoselectandevolveaggregationresistantproteins AT davidjbrockwell aninvivoplatformtoselectandevolveaggregationresistantproteins AT jessicasebo invivoplatformtoselectandevolveaggregationresistantproteins AT janetcsaunders invivoplatformtoselectandevolveaggregationresistantproteins AT paulwadevine invivoplatformtoselectandevolveaggregationresistantproteins AT alicemgordon invivoplatformtoselectandevolveaggregationresistantproteins AT amyswarwick invivoplatformtoselectandevolveaggregationresistantproteins AT bobschiffrin invivoplatformtoselectandevolveaggregationresistantproteins AT staceyechin invivoplatformtoselectandevolveaggregationresistantproteins AT elizabethengland invivoplatformtoselectandevolveaggregationresistantproteins AT jamesdbutton invivoplatformtoselectandevolveaggregationresistantproteins AT christopherlloyd invivoplatformtoselectandevolveaggregationresistantproteins AT nicholasjbond invivoplatformtoselectandevolveaggregationresistantproteins AT alisoneashcroft invivoplatformtoselectandevolveaggregationresistantproteins AT sheenaeradford invivoplatformtoselectandevolveaggregationresistantproteins AT davidclowe invivoplatformtoselectandevolveaggregationresistantproteins AT davidjbrockwell invivoplatformtoselectandevolveaggregationresistantproteins |
_version_ |
1718390182393151488 |